Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma
about
Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndromeEctopic lymphoid neogenesis in rheumatic autoimmune diseases.A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion.Emerging biotherapies for Sjögren's syndrome.Biological therapies in primary Sjögren's syndrome.B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies.Blisibimod for treatment of systemic lupus erythematosus: with trials you become wiser.Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study.Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study.Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation.The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers.Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis.Tertiary Lymphoid Structures: Autoimmunity Goes Local
P2860
Q26770648-A0E055D3-088E-4031-8673-2348CEAD379EQ30235935-3987C251-08C9-45F0-8AB6-3DC088524C6CQ36016499-BBD333D7-FCCE-47B6-8B1B-D4FE1810DE45Q37729176-A01BB2B7-E5BF-4823-AE51-2BA0C49C1D4DQ37860347-80BCC314-D3A6-40AD-B3DD-2F65EF9AAE2EQ38097170-4864897B-494A-4771-AFF5-657D93E1A912Q38799791-0B738396-2526-41BC-8EE8-D6BF21FAC5FDQ39292745-6B1EFFFB-D226-4BF3-957B-25CA01D7ABEDQ41514433-119622F1-865C-479E-86A0-1AD7F0DC25FEQ42921901-4A7C1ED6-768F-458C-9438-6AC54DFF4362Q45928777-8873EF60-B949-4AE2-B00E-8EBC18B6F502Q47171530-FF7841A3-212A-4162-9817-003845811E66Q58746430-22D2DB10-C8FD-4DFF-AE13-0EEF0D2A0796
P2860
Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Resistance to rituximab therap ...... -grade parotid B-cell lymphoma
@ast
Resistance to rituximab therap ...... -grade parotid B-cell lymphoma
@en
Resistance to rituximab therap ...... -grade parotid B-cell lymphoma
@nl
type
label
Resistance to rituximab therap ...... -grade parotid B-cell lymphoma
@ast
Resistance to rituximab therap ...... -grade parotid B-cell lymphoma
@en
Resistance to rituximab therap ...... -grade parotid B-cell lymphoma
@nl
prefLabel
Resistance to rituximab therap ...... -grade parotid B-cell lymphoma
@ast
Resistance to rituximab therap ...... -grade parotid B-cell lymphoma
@en
Resistance to rituximab therap ...... -grade parotid B-cell lymphoma
@nl
P2093
P2860
P1476
Resistance to rituximab therap ...... -grade parotid B-cell lymphoma
@en
P2093
Carlo Alberto Beltrami
Francesco Curcio
Luca Quartuccio
Martina Fabris
Massimo Moretti
Maurizio Rupolo
Michele Bombardieri
Salvatore De Vita
Sandra Lombardi
P2860
P356
10.2174/1874312900802010038
P407
P577
2008-01-01T00:00:00Z